‘Should Get Vaccine Out In 2 Years': Adar Poonawalla

  • 3:20
  • Published On: March 20, 2020
Cinema View
As the government's response and public concern over the coronavirus is increasing, the medical community is looking at two aspects. First, how much testing is optimal - should we expand it beyond at-risk populations to flatten the disease curve, or does mass testing burden the healthcare system? Second, where do India and other countries stand in developing a vaccine? People are expecting a vaccine for the coronavirus pandemic. Adar Poonawalla, CEO of Serum Institute of India, the world's largest vaccine manufacturer, answers concerns over vaccines.

Related Videos

AstraZeneca Initiates A Global Withdrawal Of Its Covid-19 Vaccine
May 08, 2024 2:12
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
May 08, 2024 2:54
AstraZeneca Withdraws Covid Vaccine, Cites Commercial Reasons: Report
May 08, 2024 0:45
AstraZeneca Covid 19 Vaccine Side Effects | What Is TTS, A Rare Condition Caused By Covishield
May 01, 2024 4:03
Astrazeneca's Big U-Turn, Admits Rare Blood Clot Risk
April 30, 2024 2:21
AstraZeneca Makes Big U-Turn, Admits Covishield Can Cause Rare Side Effects
April 30, 2024 2:48
6.5% Covid Patients Tracked For A Year After Hospital Release Died: Study
August 22, 2023 1:33
Current Covid Strain Mild, 5-6 Million Covovax Doses Made: Adar Poonawalla
April 22, 2023 1:07
World's 1st Covid Nasal Vaccine Out On Republic Day
January 26, 2023 8:39
India Gets Its Own Nasal Vaccine, Booster Costs Rs. 800 Per Dose
January 26, 2023 1:18
"Isolated Events Can't Dent India's Image": Adar Poonawalla To NDTV
January 17, 2023 2:05
"We Are Trying To Engage With China": Adar Poonawalla To NDTV
January 17, 2023 1:27
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination